Clinical Trials Details

S1900B LUNGMAP - SUBSTUDY (Lung)

A Phase II Study of Selpercatinib (LOXO-292) in Patients with RET Fusion-Positive Stage IV or Recurrent Non-Small Cell Lung Cancer.

Clinical Trial Categories

  • Cancers and Other Neoplasms